Teva stock neared a profit-taking zone Wednesday, while GSK stock bounded briefly out of a chase zone on strong fourth-quarter performances for both.

The post Teva, GSK Put Up Bullish Fourth-Quarter Performances. Here’s Where Novartis Fell Short. appeared first on Investor’s Business Daily.